+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

RNA Analysis/Transcriptomics Market by Product, Technology, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5206433
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The RNA Analysis/Transcriptomics Market grew from USD 5.37 billion in 2023 to USD 5.92 billion in 2024. It is expected to continue growing at a CAGR of 10.49%, reaching USD 10.79 billion by 2030.

RNA analysis, particularly in the context of transcriptomics, involves examining the complete set of RNA transcripts within a cell or organism to understand gene expression patterns. This field is crucial for understanding biological processes, disease mechanisms, and therapeutic targets. The necessity of RNA analysis stems from its ability to provide insights into gene function and regulation, aiding in the diagnosis and treatment of diseases, drug development, and agricultural improvements. Applications are diverse, spanning oncology, genetics, molecular diagnostics, and precision medicine. End-use segments include healthcare providers, research organizations, biotechnology companies, and academic institutions.

Key growth factors include advancements in sequencing technologies, rising demand for personalized medicine, and increased funding for RNA-based research. The discovery of RNA's roles beyond traditional mRNA, such as in non-coding RNAs, represents potential opportunities for innovation. To capitalize on these, businesses should invest in developing cost-efficient and high-throughput sequencing technologies, and explore partnerships with healthcare and biotechnology firms to expand application areas.

However, challenges persist, including high costs of RNA sequencing, data interpretation complexity, and ethical concerns regarding genetic data privacy. Technological limitations in detecting rare RNA variants also impede market growth.

The market is ripe for innovation in automation and integration of AI for data analysis, which can accelerate research and enhance precision. Developing bioinformatics tools tailored for specific RNA sequencing applications presents another frontier. Continuous research on non-coding RNAs could unlock novel therapeutic pathways, further expanding market dimensions. Overall, the RNA analysis market presents a dynamic yet challenging landscape, where agility in adopting cutting-edge technologies and maintaining robust ethical standards will be key for sustained growth and innovation.

Understanding Market Dynamics in the RNA Analysis/Transcriptomics Market

The RNA Analysis/Transcriptomics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • High Inclination Toward RNA Analysis Over DNA Leading to Growth in RNA Transcriptomics Applications
    • Rising Demand for Personalized Medicine and Targeted Therapeutics
    • Growing Pharmaceutical and Biotechnology R&D Expenditure and Government Funding for Omics
  • Market Restraints
    • Expensive R&D and Issues Related to Data Management
  • Market Opportunities
    • Increasing Focus on Biomarker
    • State-of-the-art RNAi Therapies In Development
  • Market Challenges
    • Lack of Effective Bioinformatics Tools

Exploring Porter’s Five Forces for the RNA Analysis/Transcriptomics Market

Porter’s Five Forces framework further strengthens the insights of the RNA Analysis/Transcriptomics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the RNA Analysis/Transcriptomics Market

External macro-environmental factors deeply influence the performance of the RNA Analysis/Transcriptomics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the RNA Analysis/Transcriptomics Market

The RNA Analysis/Transcriptomics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the RNA Analysis/Transcriptomics Market

The RNA Analysis/Transcriptomics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the RNA Analysis/Transcriptomics Market

The RNA Analysis/Transcriptomics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the RNA Analysis/Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include Acobiom, Affymetrix, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., CD Genomics, Cenix BioScience GmbH, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, GenXPro GmbH, Illumina, Inc., Lexogen GmbH, Merck KGaA, Pacific Bioscience of California, Inc., Promega Corporation, QIAGEN N.V., Sequentia Biotech SL, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the RNA Analysis/Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Instruments
    • Reagents or Consumables
    • Services
    • Software
  • Technology
    • Microarrays
    • Polymerase Chain Reaction
    • RNA Interference
    • Sequencing
  • Application
    • Clinical Diagnostics
    • Comparative Transcriptomics
    • Drug Discovery
    • Toxicogenomics
  • End-User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospitals
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. RNA Analysis/Transcriptomics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High Inclination Toward RNA Analysis Over DNA Leading to Growth in RNA Transcriptomics Applications
5.1.1.2. Rising Demand for Personalized Medicine and Targeted Therapeutics
5.1.1.3. Growing Pharmaceutical and Biotechnology R&D Expenditure and Government Funding for Omics
5.1.2. Restraints
5.1.2.1. Expensive R&D and Issues Related to Data Management
5.1.3. Opportunities
5.1.3.1. Increasing Focus on Biomarker
5.1.3.2. State-of-the-art RNAi Therapies In Development
5.1.4. Challenges
5.1.4.1. Lack of Effective Bioinformatics Tools
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. RNA Analysis/Transcriptomics Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents or Consumables
6.4. Services
6.5. Software
7. RNA Analysis/Transcriptomics Market, by Technology
7.1. Introduction
7.2. Microarrays
7.3. Polymerase Chain Reaction
7.4. RNA Interference
7.5. Sequencing
8. RNA Analysis/Transcriptomics Market, by Application
8.1. Introduction
8.2. Clinical Diagnostics
8.3. Comparative Transcriptomics
8.4. Drug Discovery
8.5. Toxicogenomics
9. RNA Analysis/Transcriptomics Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Hospitals
9.5. Pharmaceutical & Biotechnology Companies
10. Americas RNA Analysis/Transcriptomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific RNA Analysis/Transcriptomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa RNA Analysis/Transcriptomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Acobiom
14.1.2. Affymetrix, Inc.
14.1.3. Agilent Technologies, Inc.
14.1.4. Bio-Rad Laboratories, Inc.
14.1.5. CD Genomics
14.1.6. Cenix BioScience GmbH
14.1.7. Danaher Corporation
14.1.8. Eurofins Scientific
14.1.9. F. Hoffmann-La Roche Ltd.
14.1.10. Fluidigm Corporation
14.1.11. GenXPro GmbH
14.1.12. Illumina, Inc.
14.1.13. Lexogen GmbH
14.1.14. Merck KGaA
14.1.15. Pacific Bioscience of California, Inc.
14.1.16. Promega Corporation
14.1.17. QIAGEN N.V.
14.1.18. Sequentia Biotech SL
14.1.19. Thermo Fisher Scientific, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. RNA ANALYSIS/TRANSCRIPTOMICS MARKET RESEARCH PROCESS
FIGURE 2. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
FIGURE 3. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RNA ANALYSIS/TRANSCRIPTOMICS MARKET DYNAMICS
FIGURE 7. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RNA ANALYSIS/TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS OR CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. DENMARK RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. DENMARK RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. EGYPT RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. EGYPT RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. EGYPT RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. EGYPT RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. FINLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. FINLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. FINLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. FINLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. NORWAY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. NORWAY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. NORWAY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. NORWAY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. POLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. POLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. POLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. POLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. TURKEY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. TURKEY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. TURKEY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. TURKEY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. RNA ANALYSIS/TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 194. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. RNA ANALYSIS/TRANSCRIPTOMICS MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the RNA Analysis/Transcriptomics Market, which are profiled in this report, include:
  • Acobiom
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Cenix BioScience GmbH
  • Danaher Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • GenXPro GmbH
  • Illumina, Inc.
  • Lexogen GmbH
  • Merck KGaA
  • Pacific Bioscience of California, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Sequentia Biotech SL
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information